HUP0000759A3 - Dosage forms comprising separate portions of r- and s-enantiomers - Google Patents

Dosage forms comprising separate portions of r- and s-enantiomers

Info

Publication number
HUP0000759A3
HUP0000759A3 HU0000759A HUP0000759A HUP0000759A3 HU P0000759 A3 HUP0000759 A3 HU P0000759A3 HU 0000759 A HU0000759 A HU 0000759A HU P0000759 A HUP0000759 A HU P0000759A HU P0000759 A3 HUP0000759 A3 HU P0000759A3
Authority
HU
Hungary
Prior art keywords
enantiomers
dosage forms
separate portions
separate
portions
Prior art date
Application number
HU0000759A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Darwin Discovery Ltd Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9704978.7A external-priority patent/GB9704978D0/en
Priority claimed from GBGB9719261.1A external-priority patent/GB9719261D0/en
Application filed by Darwin Discovery Ltd Cambridge filed Critical Darwin Discovery Ltd Cambridge
Publication of HUP0000759A2 publication Critical patent/HUP0000759A2/hu
Publication of HUP0000759A3 publication Critical patent/HUP0000759A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HU0000759A 1997-03-11 1998-03-11 Dosage forms comprising separate portions of r- and s-enantiomers HUP0000759A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9704978.7A GB9704978D0 (en) 1997-03-11 1997-03-11 Dosage forms
GBGB9719261.1A GB9719261D0 (en) 1997-09-10 1997-09-10 Dosage forms
US09/038,873 US6056968A (en) 1997-03-11 1998-03-11 Pharmaceutical drug dosage forms providing different release rates
PCT/GB1998/000726 WO1998040053A1 (en) 1997-03-11 1998-03-11 Dosage forms comprising separate portions of r- and s-enantiomers

Publications (2)

Publication Number Publication Date
HUP0000759A2 HUP0000759A2 (hu) 2000-10-28
HUP0000759A3 true HUP0000759A3 (en) 2000-11-28

Family

ID=27268767

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000759A HUP0000759A3 (en) 1997-03-11 1998-03-11 Dosage forms comprising separate portions of r- and s-enantiomers

Country Status (15)

Country Link
US (2) US6056968A (https=)
EP (1) EP0969818B1 (https=)
JP (1) JP2001514651A (https=)
CN (1) CN1251987A (https=)
AT (1) ATE275394T1 (https=)
AU (1) AU741821B2 (https=)
BR (1) BR9808325A (https=)
CA (1) CA2285407C (https=)
DE (1) DE69826113T2 (https=)
ES (1) ES2227814T3 (https=)
HU (1) HUP0000759A3 (https=)
IL (1) IL131713A (https=)
NO (1) NO994412L (https=)
PL (1) PL335619A1 (https=)
WO (1) WO1998040053A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
JP2002531431A (ja) * 1998-12-02 2002-09-24 ダーウィン・ディスカバリー・リミテッド 治療用製品およびその使用
AU3064800A (en) * 1999-01-21 2000-08-07 Darwin Discovery Limited The therapeutic use of r-warfarin as anticoagulant
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
EP1313460A2 (en) * 1999-11-09 2003-05-28 Darwin Discovery Limited Therapeutic use and formulation of (-)-tramadol
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
WO2001064202A2 (en) 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
BR0114395A (pt) * 2000-10-03 2005-08-16 Penwest Pharmaceuticals Compan Composição farmacêutica para administração por suprimento via oral
CA2426811A1 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
US6562871B1 (en) * 2000-11-06 2003-05-13 Boehringer Ingelheim Pharmaceuticals, Inc. Dry granulation of pharmaceutical formulation comprising mexiletine
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
IN191028B (https=) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6780891B2 (en) 2001-11-30 2004-08-24 Sepracor Inc. Tramadol analogs and uses thereof
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
AU2003275953A1 (en) * 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
WO2004071501A1 (en) * 2003-02-10 2004-08-26 Shire Biochem Inc. Enantiomeric amphetamine compositions for the treatment of adhd
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
AU2004246837B2 (en) * 2003-06-06 2009-07-16 Ethypharm Orally-dispersible multilayer tablet
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
US8734850B2 (en) 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
CN101031322A (zh) * 2004-10-01 2007-09-05 日本脏器制药株式会社 固体药物制剂
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
US8206742B2 (en) * 2006-01-12 2012-06-26 Wockhardt Ltd. Sustained release compositions of alfuzosin
WO2007114376A1 (ja) * 2006-03-30 2007-10-11 Nippon Zoki Pharmaceutical Co., Ltd. 固形医薬製剤
CN101674728A (zh) * 2007-02-12 2010-03-17 Dmi生物科学公司 降低曲马多的副作用
CN101657101B (zh) * 2007-02-12 2013-12-11 Dmi生物科学公司 并存早泄和勃起功能障碍的治疗
EP2322168A1 (en) 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818541A (en) * 1987-08-19 1989-04-04 Schering Corporation Transdermal delivery of enantiomers of phenylpropanolamine
US5145866A (en) * 1991-04-22 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Method of treating anxiety with the aid of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4319438C1 (de) * 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
GB9412689D0 (en) * 1994-06-23 1994-08-10 Chiroscience Ltd Cytotoxic agent and its use

Also Published As

Publication number Publication date
IL131713A (en) 2004-08-31
HUP0000759A2 (hu) 2000-10-28
ATE275394T1 (de) 2004-09-15
EP0969818B1 (en) 2004-09-08
CA2285407A1 (en) 1998-09-17
CA2285407C (en) 2006-08-01
CN1251987A (zh) 2000-05-03
DE69826113D1 (de) 2004-10-14
JP2001514651A (ja) 2001-09-11
ES2227814T3 (es) 2005-04-01
EP0969818A1 (en) 2000-01-12
AU741821B2 (en) 2001-12-13
US6056968A (en) 2000-05-02
US6221394B1 (en) 2001-04-24
IL131713A0 (en) 2001-03-19
AU6508998A (en) 1998-09-29
BR9808325A (pt) 2000-05-16
PL335619A1 (en) 2000-05-08
NO994412D0 (no) 1999-09-10
WO1998040053A1 (en) 1998-09-17
DE69826113T2 (de) 2005-01-20
NO994412L (no) 1999-10-20

Similar Documents

Publication Publication Date Title
HUP0000759A3 (en) Dosage forms comprising separate portions of r- and s-enantiomers
HUP9901454A3 (en) Dosage form of ibuprofen
ZA987551B (en) Solid pharmaceutical dosage forms
SI0948541T1 (sl) PTHrP analogi
ZA951374B (en) Ranitidine solid dosage form
PL337799A1 (en) Sertralin dosage forms of retarded release
HRP980378B1 (en) Encapsulated solution dosage forms of sertraline
PL338781A1 (en) Dosage form
HK1022647A (en) Dosage forms comprising separate portions of r- and s-enantiomers
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps
GB9718683D0 (en) Novel dosage form
HU9700442D0 (en) Compounds of pharmaceutical activity
IL120398A0 (en) Low dosage contraceptive
HU9701917D0 (en) New compound of medicinal activity
TW314782U (en) Improved structure of mask
TW398283U (en) Improved structure of mask
TW317745U (en) Improved structure of mini-duster
TW323471U (en) Improved structure of hairclip
TW312131U (en) Improved structure of earflaps
IL122503A0 (en) Game of chance
TW322782U (en) Structure improvement of walker
HU9702369D0 (en) Pharmaceutical composition of natural active components